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Systematic Review
Clinical Outcomes of Superior Capsular
Reconstruction for Massive, Irreparable Rotator Cuff
Tears: A Systematic Review Comparing Acellular
Dermal Allograft and Autograft Fascia Lata
Tyler J. Smith, D.O., Anirudh K. Gowd, M.D., John Kunkel, D.O., Lisa Kaplin, D.O.,
John B. Hubbard, M.D., Kevin E. Coates, M.D., Benjamin R. Graves, M.D., and
Brian R. Waterman, M.D.
Purpose: To investigate clinical outcomes after superior capsular reconstruction (SCR) for the treatment of massive and/
or irreparable rotator cuff tears treated with either allograft or autograft. Methods: Using the Preferred Reporting Items
for Systematic Reviews and Meta Analyses (PRISMA) guidelines, in April 2020 a systematic review was performed using
PubMed, MEDLINE, EMBASE, and Cochrane databases. Clinical studies were assessed for patient-reported outcomes and
range of motion, comparing dermal allografts to fascia lata autografts, with a minimum follow-up of 12 months.
Results: A total of 16 clinical studies involving 598 patients (606 shoulders) were included for data analysis, with a
weighted mean follow-up of 36.9 months (range 12 to 60). Visual analogue scale (VAS) pain scores decreased from 4.0 to
6.9 mm preoperatively to 0 to 2.5 mm postoperatively. American Shoulder & Elbow Surgeons score increased from 20.3 to
54.5 preoperatively to 73.7 to 97.0 postoperatively. Forward flexion increased from 27.0 to 142.7 preoperatively to
134.5 to 167.0 postoperatively. External rotation increased from 13.2 to 41.0 preoperatively to 30.0 to 59.0
postoperatively. Acromiohumeral distance increased from 3.4 to 7.1 mm preoperatively to 6.0 to 9.7 mm postoperatively.
The total rates of complications, graft failure, and revision surgery were 5.6%, 13.9%, and 6.9%, respectively.
Conclusions: Irrespective of tissue source, SCR serves as a reasonable joint-preserving option for massive, irreparable
rotator cuff tears, with favorable short- to midterm improvements in patient-reported outcomes and range of motion.
Level of Evidence: IV, systematic review of level III and IV studies.
The management of massive or irreparable rotatorcuff tears is particularly complex for orthopedic
surgeons. Technical challenges include the presence of
muscle atrophy, fatty infiltration, scarring or adhesions,
myotendinous retraction, tendon inelasticity, superior
migration of the humeral head, and ultimately, osteo-
arthritis.1-5 In addition, retear rates of primary repair for
massive rotator cuff tears have been reported to be as
high as 94% within 36 months.6 Treatment options
vary and include arthroscopic debridement, tendon
transfer, interpositional arthroplasty, subacromial
spacer interposition, reverse shoulder arthroplasty
(RSA), and superior capsular reconstruction (SCR).
RSA has become increasingly popular over the last 2
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decades and accounts for nearly half of all shoulder
arthroplasty performed today.7 However, there are
concerns regarding the complication rate of RSA and
the associated revision burden, particularly in younger
patients.8-10
Historically, rotator cuff surgery has focused on
reestablishing the tendinous attachment to its footprint.
More recently, authors have proposed that the superior
capsule may serve as a more integral structure,
whereby restoration of superior capsular defects may
have a greater impact on subsequent glenohumeral
biomechanics.11 SCR has become increasingly popular
in the United States and Europe for the treatment of
massive or irreparable rotator cuff tears.12 However, the
justification for its exponential growth has been ques-
tioned, as the literature regarding SCR is limited to
several small case series and biomechanical studies. The
purpose of this study was to investigate clinical out-
comes after SCR for the treatment of massive or irrep-
arable rotator cuff tears treated with either allograft or
autograft. The authors hypothesized that postoperative
clinical outcomes would demonstrate pain reduction,
improved shoulder function, and improved range of
motion, and that SCR with fascia lata grafts would




A systematic review was registered with PROSPERO
and performed using Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
guidelines. A comprehensive literature search was
performed using PubMed, Medline (Ovid), EMBASE
(Elsevier), and Cochrane Library (Wiley) electronic
databases in April 2020. MeSH terms were used to in-
crease sensitivity. Additionally, all references in the
included studies were cross-referenced for inclusion if
any were missed by the initial search. The final search
was completed on April 10, 2020, independently, by 2
authors (T.J.S., L.K.).
Study Eligibility
Trials were eligible for inclusion if they met the
following criteria: human or cadaveric subjects with
documented massive or irreparable rotator cuff tears,
superior capsular reconstruction, and patient outcome
after 12 months of follow-up for clinical trials. Studies
involving animals, partial rotator cuff tear, rotator cuff
repair, operative technique articles without reported
outcomes, cadaver studies, biomechanical studies, re-
view articles, comments, letters, editorials, duplicates,
and nonrelevant studies were excluded. Case reports,
abstracts without available full text, and foreign lan-
guage articles without direct translation were excluded.
Study Selection and Data Abstraction
A full-text review was performed by 2 authors (T.J.S.,
L.K.) to confirm appropriateness for inclusion. Any
disagreement between authors during each step of the
review process was resolved by discussion. If consensus
could not be reached, final inclusion was decided by a
third reviewer (B.R.W.). A flow diagram outlining the
selection process can be found in Fig 1.
Clinical studies were assessed for multiple outcomes of
interest, including level of evidence, concomitant pro-
cedures, visual analogue scale (VAS), Constant score,
Oxford Shoulder Score (OSS), UCLA shoulder score,
American Shoulder & Elbow Surgeons score (ASES),
Subjective Shoulder Value (SSV), acromial humeral dis-
tance (AHD), rangeofmotion (ROM), patient satisfaction,
complications, reoperations, revision surgery, conversion
to reverse shoulder arthroplasty, and graft failure. Graft
failure was defined as retear confirmed by magnetic
resonance imaging (MRI) or ultrasound, partially healed
graft confirmed by MRI or ultrasound at final radiologic
follow-up, or loss of graft fixation resulting in functional
deficit. Descriptive statistics were calculated from each
included study. For continuous data,weightedmeans and
standard deviations were calculated for all subjects and
outcome parameters. Clinical studies were assessed for
patient-reported outcomes and ROM in comparison of
fascia lata autografts to acellular dermal allografts.
Data Analysis
TheMetafor packageaspart ofRStudio softwareversion
1.0.143 (R Foundation for Statistical Computing, Vienna,
Austria) was used for data analysis. Forest plots were
created for VAS, ASES, and ROM (forward flexion [FF]
and external rotation [ER]) (Figs 2, 3, 4, and 5, respec-
tively). The I2 indexwasused tomeasureheterogeneity of
included studies.13 Effect sizes were calculated using
random-effects models with the DerSimonian-Laird
estimator, as high heterogeneity precluded use of a
fixed-effects model.14,15
Risk of Bias Assessment
A funnel plot was created to assess publication bias.
Estimated treatment effect for the change in ASES score
was plotted on the x axis, and effect sizes were plotted
on the y axis.16 Study methodological quality was
assessed independently by 2 authors (T.J.S., J.K.) using
the Methodological Index for Non-randomized Studies
(MINORS) score (Table 1; Appendix).
Results
Study Identification and Assessment
The following terms were used as keywords and
appeared in the title, abstract, or keyword fields: (1)
massive rotator cuff tear (n ¼ 463); (2) irreparable
rotator cuff tear (n ¼ 278); (3) superior capsular
e2 T. J. SMITH ET AL.
reconstruction (n ¼ 98); and (4) superior capsule
reconstruction (n ¼ 73). The initial keyword search
returned 912 articles for review. After screening for
duplicate citations, 472 articles remained. After
screening for appropriateness based on the title and
abstract, 440 articles were excluded, leaving 32 articles
Fig 1. PRISMA (Preferred
Reporting Items for Systematic
Reviews and Meta-Analyses) flow
chart.
Fig 2. Forest plot demonstrating
change in visual analogue scale
(VAS) after superior capsular
reconstruction (SCR) with dermal
matrix versus fascia lata grafts.
Abbreviation: CI confidence
interval.
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for full text review. Of those 32, 5 were case reports, 8
were abstracts without available full text, and 3 did not
meet the minimum follow-up. Sixteen studies, all level
of evidence III or IV, reporting clinical outcomes were
included in the final review for data extraction and
analysis (Fig 1).12,17-31 All studies lacked randomization
or a control group. The mean MINORS score for all
studies included was 12.4 (Table 1; Appendix). A
funnel plot was created to assess publication bias. Esti-
mated treatment effect for the ASES were plotted on
the x axis, and effect sizes were plotted on the y axis.
Point estimates were verified to be symmetric around
the real estimated treatment effect to demonstrate
limited publication. However, 7 studies were outside
the funnel, which would suggest heterogeneity in
results (Fig 6).16
Fig 3. Forest plot demonstrating
change in American Shoulder &
Elbow Surgeons Score (ASES) af-
ter superior capsular reconstruc-
tion (SCR) with dermal matrix
versus fascia lata grafts. Abbrevi-
ation: CI confidence interval.
Fig 4. Forest plot demonstrating
change in forward flexion (FF)
after superior capsular recon-
struction (SCR) with dermal ma-
trix versus fascia lata grafts.
Abbreviation: CI confidence
interval.
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Study and Patient Characteristics
Of the 16 clinical studies, 6 involved fascia lata au-
tografts,12,18,22-24,31 8 involved acellular dermal matrix
allografts,17,19,20,25,27-30 1 involved both fascia lata and
dermal matrix grafts,21 and 1 study involved autologous
hamstring grafts.26 In total, 606 shoulders (598 pa-
tients) treated with superior capsular reconstruction
were pooled for evaluation, with a weighted mean
follow-up of 36.9 months (range 12 to 60). Graft types
were fascia lata in 294 patients (49.2%), dermal matrix
in 264 (44.1%), hamstring autograft in 8 (1.3%), and
not disclosed in 32 (5.4%). Graft thickness was a min-
imum of 5 mm (range 5 to 8) in 294 patients (49.2%), 1
to 3.5 mm in 264 (44.1%), and not disclosed in 40
(6.7%). All of the 5- to 8-mm grafts were fascia lata
grafts, and all of the 1- to 3.5-mm grafts were dermal
matrix grafts. The mean follow-up by graft type was
46.8, 24.2, and 12 months for fascia lata, dermal matrix,
and hamstring grafts, respectively.
Clinical Outcomes
After SCR, the standard mean difference between
postoperative and preoperative state was demonstrated
with respect to the VAS score, ASES score, FF, and ER
(Figs 2, 3, 4, and 5, respectively). VAS scores were re-
ported in 10 studies, and all studies reported
improvements from preoperative (range 4.0 to 6.9 mm)
to postoperative (range 0 to 2.5 mm)
values.17,19,20-22,25,27,28,30,31 ASES scores were reported
in 13 studies, and all studies reported improvements
from preoperative (range 20.3 to 54.5) to postoperative
(range 73.7 to 97.0) values.12,17,19-25,27,28,30,31 The
change in FF was reported in 12 studies, with all studies
reporting improvements from preoperative (range
27.0 to 142.7) to postoperative (range 134.5 to
167.0) values.12,17-19,21-24,27,29,30,31 The change in ER
was reported in 10 studies, with all studies reporting
improvements from preoperative (range 13.2 to 41.0)
to postoperative (range 30.0 to 59.0)
values.12,17-19,21-23,27,30,31 Constant scores were re-
ported in 4 studies, all demonstrating improvements
from preoperative (range 17.5 to 56.3) to postoperative
(range 63.7 to 83.5) values.18,21,22,26 Japanese Ortho-
paedic Association scores were reported in 3 studies, all
demonstrating improvements from preoperative (range
40.6 to 61.2) to postoperative (range 90.6 to 95.2)
values.12,24,31 AHD was reported in 12 studies, and
demonstrated improvements from preoperative (range
3.4 to 7.1 mm ) to postoperative (range 6.0 to 9.7 mm)
values in 11 studies.12,18-22,25-27,30,31 One study
demonstrated a decreased mean AHD postoperatively;
however, this finding was not statistically significant
(P ¼ .6).17
Clinical Outcomes by Graft Type
Clinical studies were differentiated by graft type for
subgroup analysis. One study using both fascia lata and
dermal matrix grafts did not differentiate outcomes for
each subgroup and was therefore excluded.21 For SCR
with dermal allografts, mean VAS improved from 4.0 to
6.3 mm preoperatively to 0 to 1.7 mm postoperatively,
mean ASES 41.8 to 54.0 versus 73.7 to 92.3, mean FF
from 27.0 to 140.0 versus 137.0 to 167.0, mean ER
from 24.0 to 41.0 versus 35.0 to 59.0, and mean
AHD from 3.4 to 7.1 mm versus 6.0 to 9.7 mm. For
SCR with fascia lata autografts, mean VAS improved
from 6.0 to 6.9 mm preoperatively to 0.9 to 2.5 mm
postoperatively, mean ASES from 20.3 to 54.4 versus
77.5 to 97.0, mean FF from 36.7 to 142.7
versus 143.8 to 163.6, mean ER from 13.2 to 32.0
versus 30.0 to 44.0, and mean AHD from 4.6 to 6.4
mm versus 6.4 to 8.7 mm.
Fig 5. Forest plot demonstrating
change in external rotation (ER)
after superior capsular recon-
struction (SCR) with dermal ma-
trix versus fascia lata grafts.
Abbreviation: CI confidence
interval.
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Mihata et al. 201312 23/24 65.1 34.1  Retrospective case series (level IV)
 Comparison between retear (þ) and retear (e) groups
 No adjustment of confounding variables




10/10 69 12.9  Retrospective case series (level IV)
 Power analysis included
 No control/comparison groups




8/8 59.6 12  Prospective case series (level IV)
 No control/comparison groups




86/88 59.4 16 to 28, no
mean reported
 Retrospective case series (level IV)
 No control/comparison groups
 No adjustment of confounding variables
11/16
Lee and Min 201821 32/36 60.9 24.8  Retrospective-case series (level IV)
 Comparison between retear (þ) and retear (e) groups
 Adjustment of confounding variables included between
retear groups
 Power analysis and pilot study included




22/22 64.8 Minimum 24, no
mean reported
 Prospective case series (level IV)
 Multiple subgroup comparisons included
 Power analysis included
 No adjustment of confounding variables
 No control group
14 /16
Denard et al. 201819 59/59 62 17.7  Prospective case series (level IV)
 No control/comparison groups
 No adjustment of confounding variables
10/16
Mihata et al. 201824 88/88 65.3 60  Retrospective case series (level IV)
 No control/comparison groups




9/9 61.3 32.4  Prospective case series (level IV)
 Historical control group underwent primary RTC repair
 No adjustment of confounding variables
12/16
Lim et al. 201922 31/31 65.3 15  Retrospective case series (level IV)
 Comparison between retear (þ) and retear (e) groups
 Adjustment of confounding variables included between
retear groups
 No control group
13/16
Mihata et al. 201823 100/100 66.9 48  Retrospective comparison study (level III)
 Comparison between subgroups
 No adjustment of confounding variables




41/41 64 34  Retrospective case series (level IV)
 Subgroup comparisons between 12 mo and 24 mo
follow-up





18/18 63 Minimum 12, no
mean reported
 Retrospective case series (level IV)
 Subgroup comparisons between ultrasounds performed
<6 and >12 mo
 No adjustment of confounding variables
 No control
13/16
Polacek 201929 19/20 60 Minimum 12, no
mean reported
 Prospective case series (level IV)
 Subgroup comparisons between 6- and 12-mo
follow-up
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Complications, Reoperations, and Graft Failures
From all cases of SCR, there were 82 incidences
(13.9%) of retear, loss of fixation, or partially healed
graft at final radiologic follow-up (range 0% to 47.6%).
Of the 82 reported failures, 53 reports included the site
of retear or graft failure. Failure occurred on the hu-
meral side in 37 cases (69.8%), intrasubstance in 9
cases (16.9%), and at the glenoid fixation in 7 cases
(13.2%). There were 42 revision surgeries performed
(6.9%, range 0% to 36.1%; 19 revision SCR, 11 RSA,
and 2 balloon spacers). No studies disclosed whether
grafts were reused during revision SCR procedures.
There were 34 complications among all surgeries
(5.6%, range 0% to 15%) (Table 2).
Discussion
This systematic review suggests that SCR for massive
or irreparable rotator cuff tears produces favorable
short-term outcomes, with resultant improvements in
pain, ROM, and other patient-reported outcomes,
irrespective of graft type. In addition, the findings
demonstrated low rates of SCR graft failure (13.9%),
complications (5.6%), and revision surgeries (6.9%) at
a mean follow-up of >3 years. These outcomes are
especially encouraging given the reported retear rates
after primary repair of massive, irreparable rotator cuff
tears being as high as 94%.6 By comparison, the post-
operative complication rate of RSA has been reported to
be as high as 39%, with increasing rates among
younger patient groups.10,32
Recently published systematic reviews have echoed
these findings, reporting short-term improvements af-
ter SCR in both subjective and objective outcomes,
including significant improvements in forward eleva-
tion and ER.12,33,34 Catapano et al.35 published a
qualitative review of 10 clinical studies in 2019. They
reported improvements in VAS, ASES, FF, and ER, with
a retear rate ranging from 3.4% to 36.1%. However,
that review included 2 studies that were excluded from
our review (1 case report, 1 abstract only).36,37 Galvin
et al.33 published a qualitative review of 5 clinical
studies and 5 biomechanical SCR studies in 2019 and
reported mean improvements in VAS, ROM, and
patient-reported outcomes. Sochacki et al.34 published
a systematic review of SCR clinical studies in 2019 and
showed statistically significant improvements in VAS,
ASES, FF, and ER. The average complication, reopera-
tion, and graft failure rates were 3.8%, 11.7%, and
14.2%, respectively. However, that review involved
only 6 clinical studies, one of which was a case
report.19-21,23,25,38
Graft Type and Thickness
The native superior capsule ranges in thickness from
4.4 to 9.1 mm.39 Mihata et al.12 initially described SCR
with a folded, 6- to 8-mm fascia lata autograft. How-
ever, concerns of donor site morbidity, shorter opera-
tive duration, and ease of graft preparation have led
authors in North America to primarily use thinner, 1- to
3-mm commercially available dermal allo-
grafts.17,19,20,25 Until recently, few studies have
compared the 2 most popular graft types. Galvin
et al.,33 in the qualitative review of 5 clinical and 5
cadaveric studies, suggested improved glenohumeral
stability and decreased subacromial contact pressures
with 8-mm fascia lata grafts compared with 4-mm
acellular dermal allografts. This conclusion was drawn
mainly from the biomechanical cadaveric studies by
Mihata and colleagues,40,41 which demonstrate
improved restoration of glenohumeral mechanics,
decreased thinning, and decreased elongation with a
thicker graft. In their recent systematic review, Mako-
vicka et al.42 described SCR outcomes among various
graft types in 9 clinical and 8 biomechanical studies.









Lacheta et al. 202030 22/22 56 25  Prospective case series (level IV)
 Subgroup comparisons between retear (þ) and
retear (e)
 Subgroup comparisons between patients with/without
prior RTC repair
 Power analysis included
 No adjustment of confounding variables
 No control
14/16
Mihata et al. 201931 30/30 68 Minimum 60, no
mean reported
 Retrospective case series (level IV)
 Subgroup comparisons between retear (þ) and
retear (e)
 Subgroup comparisons between 1- and 5-y follow-up
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translation, subacromial forces, FF, ER, and patient-
reported outcomes. However no direct, quantitative
comparison among graft types was performed in that
review.42 Interestingly, our analysis of the available
clinical data comparing fascia lata autografts and dermal
allografts shows similar improvements in VAS, ASES,
FF, and ER between these grafts. Despite differences
found in biomechanical studies, either graft may be an
acceptable option for SCR, with favorable short-term
improvements in pain, ROM, and patient-reported
outcome scores.
Graft Failures
A common debate when discussing graft types in SCR
is the difference in failure rate. Previous studies have
suggested that grafts thicker than 3 mm outperform
thinner grafts, with lower failure rates.19,20 Lee et al.21
reported that grafts >6 mm were more likely to restore
the AHD, demonstrating a statistically significant asso-
ciation with graft healing (P < .04). We found the rate
of graft failure to be higher in dermal allografts versus
fascia lata grafts (16.7% versus 9.2%, respectively).
However, there was considerable variation in the 16
clinical studies, with 6 studies reporting failure rates of
30% or greater.17,20-22,29,30 In contrast, Mihata and
colleagues23,24 reported a failure rate of 4 of 24 (16.6%)
in their initial 2013 case series,12 followed by 9 of 188
(4.8%) in subsequent 2018 studies. These findings
suggest that there may be a significant learning curve
associated with SCR.
When SCR graft failure did occur, it happened most
commonly at the site of humeral fixation (69.8%).
Hirahara et al.28 noted that as imaged by ultrasound,
dermal allografts are thickened and highly vascularized
laterally at the humeral fixation site. The authors hy-
pothesized that humeral tension and fixation are crucial
factors in regard to graft healing. Similarly, Catapano
et al.35 reported that 76.7% of graft failures in their re-
view occurred at the humeral fixation site. These find-
ings may be related to (1) greater tensile forces on the
humeral fixation site during glenohumeral ROM and (2)
acromiohumeral contact abrasion.19 However, it should
be noted that 1 study included in the present review that
reported 13 of 36 failures, all occurring on the humeral
side, performed graft fixation with a single-row tech-
nique.21 Conversely, other authors have suggested that
graft failure occurs most commonly at the glenoid fixa-
tion or midsubstance.30,43,44,45 Additional clinical studies
with long-term follow-up data are needed to determine
ideal graft tensioning, as well as to assess whether there
are significant clinical manifestations of the elongation
and thinning of the dermal allograft as observed in
biomechanical studies. Interestingly, Polacek29 reported
a 15% rate of early graft failure secondary to immuno-
logic rejection of the dermal allograft. All patients had
underlying immunologic disorders and experienced graft
disintegration within several weeks of surgery. The
optimal graft choice for SCR in patients with autoim-
mune or immunologic conditions remains unclear.
The merits of this systematic review include its large
sample size, with 606 shoulders in 598 patients. In
addition, the 16 included studies involve a variety of
graft types (fascia lata autograft, acellular dermal ma-
trix, and hamstring autograft) and a variety of graft
thicknesses (range 1 to 8 mm). This review also in-
cludes a subjective synthesis of outcomes between graft
types, which has not been analyzed in prior reviews on
this topic. In addition, although previous reviews have
demonstrated only moderate levels of heterogeneity,
the mean MINORS score for our pooled clinical studies
demonstrated a high level of methodological quality as
well as a high degree of interobserver reliability.
Limitations
We acknowledge that our analysis has several limi-
tations. First, evaluation of ROM varied between
studies, with some authors using a goniometer and
others reporting values from visual inspection. In
addition, ER was primarily measured with the arm at
the side; however, several studies reporting ER did not
specify arm position.17,22,27 Second, all of the articles
included are level of evidence III and IV, and although
several studies performed subgroup comparisons, no
studies involved a control group or randomization. In
addition, many studies failed to control for confounding
patient and/or procedural variables such as preopera-
tive shoulder function and concomitant surgeries.
Third, 7 of the included studies also demonstrated
heterogeneity among results during the risk of bias
Fig 6. A funnel plot was created to assess publication bias.
Estimated treatment effect for the American Shoulder &
Elbow Surgeons Score (ASES) were plotted on the x axis, and
effect sizes were plotted on the y axis. Point estimates were
verified to be symmetric around the real estimated treatment
effect to demonstrate limited publication bias; however, 7
studies were outside the funnel, which would suggest
heterogeneity in results.
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assessment. Although no level I or II studies currently
exist on the topic, the low level of evidence limits the
ability to pool data and provide a true quantitative
analysis, and therefore also limits the overall strength of
our conclusions. Fourth, the mean follow-up for our
clinical studies is 36.9 months. Although this is a rela-
tively short follow-up period, the longest follow-up of
any study included is 60 months. Finally, a significant
portion of the studies in this review were performed by
small groups of researchers. This may introduce bias
and falsely elevate the number of patients included in
this review, as some patients may have been included
in multiple studies.
Conclusion
Irrespective of tissue source, SCR serves as a reason-
able joint-preserving option for massive, irreparable
rotator cuff tears with favorable short- to midterm
Table 2. Outcomes after superior capsular reconstruction
Study ID Tendon Involvement Complications
Graft
Failures (%) Revision rate




NR 4/24 (16.7) 1 revision SCR
Burkhardt and Hartzler 201917 Unspecified: 2 tendons fully
torn or tear dimension >5 cm
NR 3/10 (30) 0
Rosales-Varo et al. 201926 SS (4/8)
IS (4/8)
NR (4/8)
None 0/8 (0) None
Pennington et al. 201925 Massive tear of SS or SS þ IS
No SSc or Tm
NR 4/88 (4.5) 1 RSA




NR 13/36 (36.1) 13 revision SCR




Surgical site infection (1) 2/22 (9.1) 0




Failed biceps tenodesis (1)
11/59 (18.6) 2 revision SCR
7 RSA








Gluteal muscle discomfort (1)
4/88 (4.5) 0
Hirahara et al. 201720 NR Infra-/subscapular tear (1) 3/9 (33.3) 1 RSA
Lim et al. 201922 NR NR 9/31 (29.0) 0
Mihata et al. 201823 NR Suture anchor pullout (4)
Arthrofibrosis (2)
Deep infection (2)
Gluteal muscle discomfort (1)
Infra tear (3)
5/100 (5.0) 0
Burkhart et al. 202027 SS (41/41)
IS (41/41)
SSc (30)
Traumatic rupture of biceps
tenodesis (1)
Fall (2)
4/26 (15.4) 1 revision SCR
1 RSA
Hirahara et al. 201928 NR Fall (1) 1/18 (5.6) 1 RSA
Polacek 201929 SS (20/20)
IS (1/20)
SSc (1/20)





Lacheta et al. 202030 SS (22/22)
IS (22/22)
SSc (2/22)
Recurrent loss of function (1) 10/21 (47.6) 1 revision SCR
Mihata et al. 201931 SS/IS (16/30)
SS/IS/SSc (12/30)
SS/IS/Tm (2/30)
Suture anchor pullout (1) 3/30 (10) 0
IS, infraspinatus; NR, not reported; RSA, reverse shoulder arthroplasty; SCR, superior capsular reconstruction; SS, supraspinatus; SSc, sub-
scapularis; Tm, teres minor.
CLINICAL OUTCOMES OF SUPERIOR CAPSULAR RECONSTRUCTION e9
improvements in patient-reported outcomes and range
of motion.
References
1. Gerber C, Wirth SH, Farshad M. Treatment options for
massive rotator cuff tears. J Shoulder Elbow Surg 2011;20:
S20-S29.
2. Gerber C, Fuchs B, Hodler J. The results of repair of
massive tears of the rotator cuff. J Bone Joint Surg Am
2000;82:505-515.
3. Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC.
Fatty muscle degeneration in cuff ruptures. Pre- and
postoperative evaluation by CT scan. Clin Orthop Relat Res
1994:78-83.
4. Goutallier D, Postel J-M, Gleyze P, Leguilloux P, Van
Driessche S. Influence of cuff muscle fatty degeneration on
anatomic and functional outcomes after simple suture of
full-thickness tears. J Shoulder Elbow Surg 2003;12:550-554.
5. Bedi A, Dines J, Warren RF, Dines DM. Massive tears of
the rotator cuff. J Bone Joint Surg Am 2010;92:1894-1908.
6. Galatz LM, Ball CM, Teefey SA, Middleton WD,
Yamaguchi K. The outcome and repair integrity of
completely arthroscopically repaired large and massive ro-
tator cuff tears. J Bone Joint Surg Am 2004;86:219-224.
7. Palsis JA, Simpson KN, Matthews JH, Traven S,
Eichinger JK, Friedman RJ. Current trends in the use of
shoulder arthroplasty in the United States. Orthopedics
2018;41:e416-e423.
8. Zumstein MA, Pinedo M, Old J, Boileau P. Problems,
complications, reoperations, and revisions in reverse total
shoulder arthroplasty: A systematic review. J Shoulder
Elbow Surg 2011;20:146-157.
9. Ek ETH, Neukom L, Catanzaro S, Gerber C. Reverse total
shoulder arthroplasty for massive irreparable rotator cuff
tears in patients younger than 65 years old: Results afterfive
to fifteen years. J Shoulder Elbow Surg 2013;22:1199-1208.
10. Ernstbrunner L, Suter A, Catanzaro S, Rahm S, Gerber C.
Reverse total shoulder arthroplasty for massive, irrepa-
rable rotator cuff tears before the age of 60 years: Long-
term results. J Bone Joint Surg Am 2017;99:1721-1729.
11. Adams CR, DeMartino AM, Rego G, Denard PJ,
Burkhart SS. The rotator cuff and the superior capsule:
Why we need both. Arthroscopy 2016;32:2628-2637.
12. Mihata T, Lee TQ, Watanabe C, et al. Clinical results of
arthroscopic superior capsule reconstruction for irrepa-
rable rotator cuff tears. Arthroscopy 2013;29:459-470.
13. Higgins JPT, Thompson SG, Deeks JJ, Altman DG.
Measuring inconsistency in meta-analyses. BMJ
2003;327:557-560.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials
revisited. Contemp Clin Trials 2015;45:139-145 (pt A).
15. Sidik K, Jonkman JN. A note on variance estimation in
random effects meta-regression. J Biopharm Stat 2005;15:
823-838.
16. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-
analysis detected by a simple, graphical test. Asymmetry
detected in funnel plot was probably due to true hetero-
geneity. BMJ 1998;316:469.
17. Burkhart SS, Hartzler RU. Superior capsular reconstruc-
tion reverses profound pseudoparalysis in patients with
irreparable rotator cuff tears and minimal or no gleno-
humeral arthritis. Arthroscopy 2019;35:22-28.
18. de Campos Azevedo CI, Ângelo ACLPG, Vinga S.
Arthroscopic superior capsular reconstruction with a
minimally invasive harvested fascia lata autograft pro-
duces good clinical results. Orthop J Sports Med 2018;6:
232596711880824.
19. Denard PJ, Brady PC, Adams CR, Tokish JM, Burkhart SS.
Preliminary results of arthroscopic superior capsule
reconstruction with dermal allograft. Arthroscopy 2018;34:
93-99.
20. Hirahara AM, Andersen WJ, Panero AJ. Superior capsular
reconstruction: Clinical outcomes after minimum 2-year
follow-up. Am J Orthop 2017;46:266-278.
21. Lee S-J, Min Y-K. Can inadequate acromiohumeral dis-
tance improvement and poor posterior remnant tissue be
the predictive factors of re-tear? Preliminary outcomes of
arthroscopic superior capsular reconstruction. Knee Surg
Sports Traumatol Arthrosc 2018;26:2205-2213.
22. Lim S, AlRamadhan H, Kwak J-M, Hong H, Jeon I-H. Graft
tears after arthroscopic superior capsule reconstruction
(ASCR): Pattern of failure and its correlation with clinical
outcome. Arch Orthop Trauma Surg 2019;139:231-239.
23. Mihata T, Lee TQ, Fukunishi K, et al. Return to sports and
physical work after arthroscopic superior capsule recon-
struction among patients with irreparable rotator cuff
tears. Am J Sports Med 2018;46:1077-1083.
24. Mihata T, Lee TQ, Hasegawa A, et al. Arthroscopic supe-
rior capsule reconstruction can eliminate pseudoparalysis
in patients with irreparable rotator cuff tears. Am J Sports
Med 2018;46:2707-2716.
25. Pennington WT, Chen SW, Bartz BA, Pauli JM. Arthro-
scopic superior capsular reconstruction with acellular
dermal allograft using push-in anchors for glenoid fixa-
tion. Arthrosc Tech 2019;8:e51-e55.
26. Rosales-Varo AP, Zafra M, García-Espona MA, Flores-
Ruiz MA, Roda O. Superior capsular reconstruction of
irreparable rotator cuff tear using autologous hamstring
graft. Rev Esp Cir Ortop Traumatol 2019;63:1-6.
27. Burkhart SS, Pranckun JJ, Hartzler RU. Superior capsular
reconstruction for the operatively irreparable rotator cuff
tear: Clinical outcomes are maintained 2 years after sur-
gery. Arthroscopy 2020;36:373-380.
28. Hirahara AM, Andersen WJ, Panero AJ. Ultrasound
assessment of the superior capsular reconstruction with
dermal allograft: An evaluation of graft thickness and
vascularity. Arthroscopy 2019;35:3194-3202.
29. Polacek M. Arthroscopic superior capsular reconstruction
with acellular porcine dermal xenograft for the treatment
of massive irreparable rotator cuff tears. Arthrosc Sports
Med Rehab 2019;1:e75-e84.
30. Lacheta L, Horan MP, Schairer WW, et al. Clinical and
imaging outcomes after arthroscopic superior capsule
reconstruction with human dermal allograft for irreparable
posterosuperior rotator cuff tears: A minimum 2-year
follow-up. Arthroscopy 2020;36:1011-1019.
31. Mihata T, Lee TQ, Hasegawa A, et al. Five-year follow-up of
arthroscopic superior capsule reconstruction for irreparable
rotator cuff tears. J Bone Joint Surg Am 2019;101:1921-1930.
32. Ferreira Neto AA, Malavolta EA, Assunção JH,
Trindade EM, Gracitelli MEC. Reverse shoulder
e10 T. J. SMITH ET AL.
arthroplasty: Clinical results and quality of life evaluation.
Rev Bras Ortop 2017;52:298-302.
33. Galvin JW, Kenney R, Curry EJ, et al. Superior capsular
reconstruction for massive rotator cuff tears: A critical
analysis review. JBJS Rev 2019;7:e1.
34. Sochacki KR, McCulloch PC, Lintner DM, Harris JD. Su-
perior capsular reconstruction for massive rotator cuff tear
leads to significant improvement in range of motion and
clinical outcomes: A systematic review. Arthroscopy
2019;35:1269-1277.
35. CatapanoM, de SAD, Ekhtiari S, Lin A, Bedi A, Lesniak BP.
Arthroscopic superior capsular reconstruction for massive,
irreparable rotator cuff tears: A systematic review ofmodern
literature. Arthroscopy 2019;35:1243-1253.
36. AlRamadhan H, Sungjoon L, In-Ho J. Early MRI findings
of arthroscopic superior capsule reconstruction (ASCR):
How to prevent early failure. Arthroscopy 2017;33:e21.
37. Zerr J, McDermott JD, Beckmann NM, Fullick RK,
Chhabra A. Case study: Failure of superior capsular recon-
struction using dermal allograft. Skelet Radiol 2017;46:
1585-1589.
38. Tokish JM, Momaya A, Roberson T. Superior capsular
reconstruction with a partial rotator cuff repair: A case
report. JBJS Case Connect 2018;8:e1.
39. Nimura A, Kato A, Yamaguchi K, et al. The superior
capsule of the shoulder joint complements the insertion of
the rotator cuff. J Shoulder Elbow Surg 2012;21:867-872.
40. Mihata T, Bui CNH, Akeda M, et al. A biomechanical
cadaveric study comparing superior capsule reconstruc-
tion using fascia lata allograft with human dermal allo-
graft for irreparable rotator cuff tear. J Shoulder Elbow Surg
2017;26:2158-2166.
41. Mihata T, McGarry MH, Kahn T, Goldberg I, Neo M,
Lee TQ. Biomechanical effect of thickness and tension of
fascia lata graft on glenohumeral stability for superior
capsule reconstruction in irreparable supraspinatus tears.
Arthroscopy 2016;32:418-426.
42. Makovicka JL, Chung AS, Patel KA, Deckey DG,
Hassebrock JD, Tokish JM. Superior capsule reconstruc-
tion for irreparable rotator cuff tears: A systematic review
of biomechanical and clinical outcomes by graft type.
J Shoulder Elbow Surg September 2020;29:392-401.
43. Emerson CP, Balazs GC, Lee SC, Dines JS, Jose J,
Greditzer HG. Magnetic resonance imaging of the failed
superior capsular reconstruction. Clin Imaging 2020;60:
172-176.
44. Badman BL, Moor M, Baessler A, Crackel B. Short term
comparative imaging and clinical analysis of superior
capsular reconstruction. J Shoulder Elbow Surg 2020;29:
e139-e140.
45. LaBelle MW, Peck M, Mengers S, et al. Evaluating the role
of graft integrity on outcomes: Clinical and imaging re-
sults following superior capsular reconstruction. J Shoulder
Elbow Surg 2020;29:e140-e141.
CLINICAL OUTCOMES OF SUPERIOR CAPSULAR RECONSTRUCTION e11
Appendix
Methods and Results for MINORS Criteria Scoring
MethodsdQuality Assessment
The Methodological Index for Non-randomized
Studies (MINORS) checklist was used to assess the
methodologic quality of included studies. The checklist
assigns a score of 0-2 for 8 items applicable to non-
randomized studies, with a maximum score of 16
indicating the highest possible score for an individual
non-randomized study. The items were scored 0 if not
reported; 1 when reported but inadequate; and 2 when
reported and adequate. A minimum of 12 months was
deemed appropriate length of follow-up. After thor-
ough review of MINORS scoring guidelines, 2 authors
independently reviewed and scored each included
study. Any disagreements in scoring were resolved by
consensus discussion with the senior author.
ResultsdStudy Quality
The included studies were composed of 15 case series
and 1 retrospective comparative study. All clinical
studies were non-randomized. The mean MINORS
score was 12.4 of 16.
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